Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Tuesday, October 16, 2018 · 465,301,298 Articles · 3+ Million Readers

Invivo Robotics and Leading Healthcare Group Joint Venture to Research, Develop and Manufacture Therapeutic Tools

Innovative tools to address significant need for early diagnosis and cost-effective treatment of cancer

We are excited to open our partnership focused on delivering innovative healthcare solutions in China and around the world”
— Chris Leung
SHANGHAI, CHINA, March 15, 2018 /EINPresswire.com/ -- Invivo Robotics, one of the pioneers in the rapidly emerging field of robotic-assisted minimally invasive surgery, is pleased to announce a joint venture to research, develop, manufacture and sell innovative, robotic-assisted catheter-based medical devices.
The joint venture between Invivo Robotics and a leading healthcare group strategically comprising the complete value chain, will initially produce products targeting early diagnosis and cost-effective treatment of cancer.
The technology will be used in robotic-assisted medical devices based on catheters, and incorporates proprietary intellectual property developed or owned by Invivo Robotics. The joint venture will be registered in Shanghai, where it will perform research and development activities and manufacture catheter-based products for global distribution. Distribution in China and the greater Southeast Asia Pacific region will be conducted by the joint venture. Distribution outside of China will be conducted by Invivo Robotics.
“We are excited to open our partnership focused on delivering innovative healthcare solutions in China and around the world,” said Chris Leung, Head of Global Product Development for Invivo Robotics. “We are proud to make this important long-term commitment to China.”
The companies will contribute with all the funds necessary as required by the joint venture, an arrangement representing a significant expansion of Invivo Robotics’ relationship with the healthcare group. The name of the partner will be announced at a later date, upon the signing of the contract.
“We are pleased to begin our partnership and advance the development of medical tools to enhance the wellbeing of global populations, including those in China that suffer from increased rates of cancer,” Chen G. Gexin, MD, PhD, Chief Executive Officer for Invivo Robotics said, “The cooperation will boost the development of our medical device sector by integrating branding concept, matching resources and leveraging complementary advantages so as to bring better medical tools for doctors.”

About Invivo Robotics

Invivo Robotics is one of the pioneers in the rapidly emerging field of robotic-assisted minimally invasive surgery. Invivo Robotics serves globally providing technology innovation across cardiac, thoracic, urology, gynecologic, colorectal, pediatric and general surgical disciplines. The Company's surgical systems enables surgeons to operate minimally invasively. At Invivo Robotics, delivering our technology is just the beginning. The company is also committed to delivering the best customer experience. To ensure the customers gain the most utility from their Invivo Robotics systems, the firm offers a comprehensive training and education program and first-rate customer support. Invivo Robotics has strong financial backing of leading global investors.

Kang Yong
Invivo Robotics
1852130-6369
email us here

Powered by EIN Presswire